ESC Premium Access

siRNA therapy: the dawn of a new agent in cholesterol lowering?

Congress Presentation

About the speaker

Doctor Leslie Cho

Cleveland Clinic, Cleveland (United States of America)
19 presentations
1 follower

3 more presentations in this session

PCSK9 inhibitors post Fourier: who should be treated and when?

Speaker: Professor S. Nissen (Cleveland, US)

Thumbnail

Is Lp(a) a risk factor for cardiovascular disease and is it worth treating?

Speaker: Professor E. Stroes (Amsterdam, NL)

Thumbnail

Current state of knowledge on the mechanism of action of bempedoic acid and its potential for LDL-C lowering and CV risk reduction.

Speaker: Professor S. Nicholls (Melbourne, AU)

Thumbnail

Access the full session

Cardiovascular risk reduction and dyslipidaemia management: current state and future therapies

Speakers: Doctor L. Cho, Professor S. Nissen, Professor E. Stroes, Professor S. Nicholls
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations